Open $274.17
Day Range 273.37 - 291.71
52 Week Range 223.25 - 363.92
Market Cap $41.03B
Shares Outstanding 150.55M
Public Float 150.27M
Beta 0.83
Rev. per Employee $1.358M
P/E Ratio 15.14
EPS $19.06
Yield N/A
Dividend N/A
Ex-Dividend Date N/A
Short Interest 3.04M 05/14/21
% of Float Shorted 2.02%
Average Volume 1.07M

5 Day	8.05%
1 Month	5.46%
3 Month	6.76%
YTD	18.03%
1 Year	-5.78%

Sell
Under
Hold
Over
Buy

Number of Ratings 32 Full Ratings

MarketWatch
Dow Jones

Biogen stock jumps 6.7%, enough to pace the S&P 500’s winners

Jun. 4, 2021 at 1:53 p.m. ET by Tomi Kilgore

Barron's

FDA Has a Monday Deadline to Decide on Biogen’s Alzheimer’s Drug. What to Know.

Jun. 4, 2021 at 5:00 a.m. ET by Barron's

Biogen’s pivotal moment: Will the FDA approve the experimental — and controversial — Alzheimer’s-disease drug aducanumab?

Jun. 2, 2021 at 1:24 p.m. ET by Jaimy Lee

Biogen Inc. stock rises Thursday, outperforms market

Jun. 3, 2021 at 4:40 p.m. ET by MarketWatch Automation

Barron's

FDA’s Call on Alzheimer’s Drug Is Coming. These Analysts Expect a Green Light.

Jun. 3, 2021 at 10:31 a.m. ET by Barron's

Biogen Inc. stock outperforms market on strong trading day

Jun. 2, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock outperforms competitors despite losses on the day

Jun. 1, 2021 at 4:40 p.m. ET by MarketWatch Automation

Barron's

Alzheimer’s Drug Decision Is a Big Deal for Biogen—and the Entire Biotech Sector

Jun. 1, 2021 at 9:15 a.m. ET by Barron's

Barron's

Biogen’s Alzheimer’s Drug Faces Its Moment of Truth. Biotech Investors Are Watching.

May. 28, 2021 at 8:00 p.m. ET by Barron's

Biogen Inc. stock rises Friday, still underperforms market

May. 28, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock falls Thursday, underperforms market

May. 27, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock underperforms Wednesday when compared to competitors

May. 26, 2021 at 4:40 p.m. ET by MarketWatch Automation

Barron's

Travere Therapeutics’ Disappointment Is Another Sign of a Tougher FDA

May. 26, 2021 at 8:30 a.m. ET by Barron's

Biogen Inc. stock falls Tuesday, underperforms market

May. 25, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock underperforms Monday when compared to competitors

May. 24, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock falls Friday, underperforms market

May. 21, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen, Ginkgo Bioworks in Gene-Therapy Manufacturing Platform Collaboration

May. 21, 2021 at 7:50 a.m. ET

Biogen Inc. stock outperforms competitors on strong trading day

May. 20, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock outperforms competitors on strong trading day

May. 19, 2021 at 4:40 p.m. ET by MarketWatch Automation

Biogen Inc. stock outperforms market on strong trading day

May. 18, 2021 at 4:40 p.m. ET by MarketWatch Automation

No Headlines Available

Other News
Press Releases

AbbVie's (ABBV) Skyrizi Succeeds in Crohn's Maintenance Study

Jun. 3, 2021 at 9:21 a.m. ET on Zacks.com

Here's the Biggest Challenge Biogen Will Face if Its Alzheimer's Drug Is Approved

Jun. 2, 2021 at 4:00 p.m. ET on Motley Fool

Biotech Stock Roundup: MRNA COVID-19 Vaccine Update, Drug Approvals for ALKS, MYOV & More

Jun. 2, 2021 at 11:17 a.m. ET on Zacks.com

3 Biotech Stocks With Huge Catalysts in June

Jun. 2, 2021 at 9:03 a.m. ET on Motley Fool

Will This Big Decision Knock the Biogen Roller Coaster Off the Tracks?

Jun. 2, 2021 at 8:40 a.m. ET on Motley Fool

The Best Biotech Stocks to Buy With $500

May. 31, 2021 at 6:01 a.m. ET on Motley Fool

PTC Therapeutics' (PTCT) PTC923 Gets Orphan Drug Tag in US & EU

May. 27, 2021 at 10:23 a.m. ET on Zacks.com

Is Biogen a Buy?

May. 27, 2021 at 7:45 a.m. ET on Motley Fool

ANVS Stock: The Huge News Sending Annovis Bio Rocketing 200% Today

May. 21, 2021 at 1:12 p.m. ET on InvestorPlace.com

Zacks Industry Outlook Highlights: Regeneron, Gilead Sciences, Amgen, Biogen, BioNTech, Repligen and Ovid Therapeutics

May. 21, 2021 at 8:46 a.m. ET on Zacks.com

3 Biotech Stocks to Keep an Eye On Amid the Coronavirus Mayhem

May. 20, 2021 at 9:29 a.m. ET on Zacks.com

Biotech Stock Roundup: AGEN, SRPT Surge & BIIB, REGN Provide Pipeline Updates

May. 19, 2021 at 5:06 p.m. ET on Zacks.com

Biogen (BIIB) Receives a Buy from Leerink Partners

May. 18, 2021 at 4:19 a.m. ET on SmarterAnalyst

Biogen (BIIB) Gets a Buy Rating from Oppenheimer

May. 17, 2021 at 8:55 p.m. ET on SmarterAnalyst

Biogen (BIIB) Eye Disease Drug Misses Primary Goal in Study

May. 17, 2021 at 10:19 a.m. ET on Zacks.com

Biogen (BIIB) Decides to Acquire Phase II Stroke Candidate

May. 14, 2021 at 9:30 a.m. ET on Zacks.com

The Zacks Analyst Blog Highlights: Regeneron, Moderna, Minerva Neurosciences, Amgen and Biogen

May. 13, 2021 at 9:01 a.m. ET on Zacks.com

Biotech Stock Roundup: REGN's Q1 Earnings Update, MRNA's Vaccine Data & More

May. 12, 2021 at 2:35 p.m. ET on Zacks.com

Biogen (BIIB) Signs New Gene Therapy Deal for CNS Disorders

May. 12, 2021 at 10:16 a.m. ET on Zacks.com

Biogen Collaborates With Capsigen To Develop New Gene Therapies

May. 11, 2021 at 6:18 a.m. ET on TipRanks.com

No Headlines Available

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Name	Chg %	Market Cap
Sangamo Therapeutics Inc.	0.84%	$1.55B
Johnson & Johnson	0.10%	$437.25B
Sanofi ADR	0.52%	$129.94B
AbbVie Inc.	0.30%	$198.19B
Pfizer Inc.	0.56%	$218.14B
Bio-Rad Laboratories Inc. Cl A	-0.03%	$17.37B
Acorda Therapeutics Inc.	-2.46%	$34.73M
Amgen Inc.	0.83%	$135.45B
Gilead Sciences Inc.	1.56%	$83.38B

Competitor Data Provided By